Skip to content

Compression stockings reduced leg-cramp frequency in a randomized trial

Stockings outperformed placebo pills on weekly cramp frequency; magnesium did not show a statistically significant difference from placebo.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

In adults with frequent leg cramps, compression stockings reduced cramp frequency compared with placebo pills at the main assessment. Magnesium did not show a statistically significant advantage over placebo. The abstract supports a benefit for stockings on this measured outcome, while leaving the size and durability of broader benefits uncertain.

Keep in mind

The trial was only partially blinded, and the abstract does not quantify the reported improvements in pain or cramp-related awakenings.

THE NUMBERS, WITH CONTEXT

What researchers found

-1.43 cramps per week

Baseline-adjusted mean difference in leg-cramp frequency

Stockings versus placebo pills at week 8; 95% CI -2.36 to -0.50.

Trials, 2026 · Original source ↓

What the trial tested

Participants had recurring cramps before enrollment. Researchers assigned daily stockings, magnesium, or placebo pills, then evaluated changes in weekly cramp frequency. Pain and awakenings caused by cramps were secondary outcomes.

Tolerance and uncertainty

Four participants stopped using stockings because of adverse reactions, although no serious adverse events were reported. The magnesium comparison was statistically inconclusive; it does not establish that magnesium and placebo have identical effects.

CHECK THE ORIGINAL

The original publication

Secondary prevention of leg cramps using compression stockings or magnesium supplements: a three-arm randomized clinical trial.

Kuusipalo A, Laitila J, Lehtonen E et al.
Trials · 2026

PubMed ID
41680812
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.